Skip to main content
Learning Clubs and Series First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis

First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis

Short name: AJCM222024
Course start date: 07/11/2025
Course end date: 07/11/2026

Description

ASH Journal Club: May 22, 2024, 12:00-1:00 PM Eastern Download Calendar Hold

The link to the live webinar link will appear above at the session start time. After the webinar ends, please continue to the next page to complete the evaluation.

The ASH Journal Club is a series that highlights seminal papers in hematology published in Blood, Blood AdvancesBlood Neoplasia, and Blood Vessels, Thrombosis, & Hemostasis and features a manuscript author as part of the engagement. Join us on May 22nd, 2024 to discuss “First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis” First edition Blood (2024). Published on April 4, 2024.

DOI: https://doi.org/10.1182/blood.2023021349

Learning Objectives

Join us for a discussion on the role of SETBP1 mutations and their role in the pathogenesis of myelofibrosis-like myeloproliferative disorder.  SETBP1 mutations appear in various clonal myeloid disorders, yet their oncogenic potential in leukemia is uncertain, as SETBP1 mutations typically appear as late events during oncogenesis. This article reveals that SETBP1 mutations, acting as a first-hit/early event, drive an aggressive myelofibrosis-like myeloproliferative disorder. Additionally, the authors found that somatic SETBP1 mutations can discriminate between 2 subtypes of triple-negative myelofibrosis, with different genetic landscape and aggressiveness.

Presenter:

 

Rocco Piazza, MD, PhD
San Gerardo Hospital; Monza, Italy


Moderators:

Jonas Jutzi, MD, PhD
Brigham and Women’s Hospital

Tania Jain, MD, MBBS
Johns Hopkins


Sections

General
0 activities

ASH Journal Club: May 22, 2024, 12:00-1:00 PM East...
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis
Evaluation

Text and media area Text and media area
1
Vimeo Vimeo
1
Questionnaire Questionnaire
1
Price
Free Access
Duration
30-60 minutes
Accreditation
Not Accredited
Frequently Searched Content
Image Challenges
Research
  • Pre-Clinical Models
  • Translational
Learning Level
Level 3/Subspecialty: Fellows developing general hematology expertise for board certification
Disease Types and Treatments
  • Clonal myeloid disorders
Clonal myeloid disorders
  • Myeloproliferative neoplasms
Myeloproliferative neoplasms
  • Primary myelofibrosis

Tag

Clonal myeloid disorders Myeloproliferative neoplasms Primary myelofibrosis